Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 260 Lymphoma, Non-Hodgkin 205 Leukemia, Lymphocytic, Chronic, B-Cell 193 Lymphoma, Large B-Cell, Diffuse 187 Lymphoma, Follicular 168 Lymphoma, Mantle-Cell 134 Leukemia 81 Lymphoma, B-Cell, Marginal Zone 80 Burkitt Lymphoma 54 Waldenstrom Macroglobulinemia 52 Precursor Cell Lymphoblastic Leukemia-Lymphoma 48 Lymphoma, B-Cell 47 Lymphoma, Large-Cell, Immunoblastic 42 Hodgkin Disease 39 Recurrence 35 Lymphoma, Large-Cell, Anaplastic 18 Multiple Myeloma 16 Neoplasms 13 Myelodysplastic Syndromes 12 Hematologic Neoplasms 12 Leukemia, Myeloid, Acute 11 Lymphoma, T-Cell 9 Intraocular Lymphoma 9 Dendritic Cell Sarcoma, Interdigitating 9 Leukemia, Prolymphocytic 7 Neoplasms, Plasma Cell 6 Leukemia, Hairy Cell 6 Leukemia, B-Cell 6 Graft vs Host Disease 6 Arthritis, Rheumatoid 6

Interventions

midostaurin 2 vandetanib 1 selinexor 1 pegfilgrastim 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Aggression × Rituximab × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡